Trump’s MFN Drug Pricing Policy Is Reshaping Pharmaceutical Markets
The United States is seeking to curb pharmaceutical expenditure by incorporating international price referencing into public health insurance programs.
Welcome Tanja Karvonen!
Tanja joined Medaffcon’s Market Access team in November 2016
Tanja gained her most recent work experience as a researcher at the National Institute for Health and Welfare. In addition, Tanja has worked, among other things, in an international research group.
She completed her MSc in Health Economics at the University of York in 2013 and holds a Master’s degree in the field of Economics and Business Administration from previous studies.
Tanja’s experience in conducting registry studies expands Medaffcon’s knowledge base to a whole new area.
A warm welcome to Tanja!
